Intarak Sararas, Chongpison Yuda, Vimolnoch Mananchaya, Oonsiri Sornjarod, Kitpanit Sarin, Prayongrat Anussara, Kannarunimit Danita, Chakkabat Chakkapong, Sriswasdi Sira, Lertbutsayanukul Chawalit, Rakvongthai Yothin
Medical Physics Program, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Chulalongkorn University Biomedical Imaging Group, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Front Oncol. 2022 Jan 28;12:775248. doi: 10.3389/fonc.2022.775248. eCollection 2022.
We aimed to construct predictive models for the overall survival (OS), progression-free survival (PFS), and distant metastasis-free survival (DMFS) for nasopharyngeal carcinoma (NPC) patients by using CT-based radiomics.
We collected data from 197 NPC patients. For each patient, radiomic features were extracted from the CT image acquired at pretreatment PyRadiomics. Feature selection was performed in two steps. First, features with high inter-observer variability based on multiple tumor delineations were excluded. Then, stratified bootstrappings were performed to identify feature combinations that most frequently achieved the highest (i) area under the receiver operating characteristic curve (AUC) for predicting 3-year OS, PFS, and DMFS or (ii) Harrell's C-index for predicting time to event. Finally, regularized logistic regression and Cox proportional hazard models with the most frequently selected feature combinations as input were tuned using cross-validation. Additionally, we examined the robustness of the constructed model to variation in tumor delineation by simulating 100 realizations of radiomic feature values to mimic features extracted from different tumor boundaries.
The combined model that used both radiomics and clinical features yielded significantly higher AUC and Harrell's C-index than models using either feature set alone for all outcomes ( < 0.05). The AUCs and Harrell's C-indices of the clinical-only and radiomics-only models ranged from 0.758 ± 0.091 to 0.789 ± 0.082 and from 0.747 ± 0.062 to 0.767 ± 0.074, respectively. In comparison, the combined models achieved AUC of 0.801 ± 0.075 to 0.813 ± 0.078 and Harrell's C-indices of 0.779 ± 0.066 to 0.796 ± 0.069. The results showed that our models were robust to variation in tumor delineation with the coefficient of variation ranging from 4.8% to 6.4% and from 6.7% to 9.3% for AUC and Harrell's C-index, respectively.
Our results demonstrated that using CT-based radiomic features together with clinical features provided superior NPC prognostic prediction than using either clinical or radiomic features alone.
我们旨在通过基于CT的放射组学构建鼻咽癌(NPC)患者总生存期(OS)、无进展生存期(PFS)和无远处转移生存期(DMFS)的预测模型。
我们收集了197例NPC患者的数据。对于每位患者,使用PyRadiomics从治疗前获取的CT图像中提取放射组学特征。特征选择分两步进行。首先,基于多个肿瘤轮廓排除观察者间变异性高的特征。然后,进行分层自抽样以识别最常实现以下目标的特征组合:(i)预测3年OS、PFS和DMFS的受试者操作特征曲线(AUC)下面积最高;或(ii)预测事件发生时间的Harrell's C指数最高。最后,使用交叉验证调整以最常选择的特征组合作为输入的正则化逻辑回归和Cox比例风险模型。此外,我们通过模拟100次放射组学特征值实现来检查构建模型对肿瘤轮廓变化的稳健性,以模拟从不同肿瘤边界提取的特征。
对于所有结局,使用放射组学和临床特征的联合模型产生的AUC和Harrell's C指数显著高于单独使用任何一种特征集的模型(<0.05)。仅临床模型和仅放射组学模型的AUC和Harrell's C指数分别在0.758±0.091至0.789±0.082以及0.747±0.062至0.767±0.074之间。相比之下,联合模型的AUC为0.801±0.075至0.813±0.078,Harrell's C指数为0.779±0.066至0.796±0.069。结果表明,我们的模型对肿瘤轮廓变化具有稳健性,AUC和Harrell's C指数的变异系数分别为4.8%至6.4%和6.7%至9.3%。
我们的结果表明,与单独使用临床或放射组学特征相比,结合基于CT的放射组学特征和临床特征可提供更优的NPC预后预测。